Cargando…
Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation
Loss of either hepatocyte growth factor activator inhibitor (HAI)-1 or -2 is associated with embryonic lethality in mice, which can be rescued by the simultaneous inactivation of the membrane-anchored serine protease, matriptase, thereby demonstrating that a matriptase-dependent proteolytic pathway...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431340/ https://www.ncbi.nlm.nih.gov/pubmed/22952456 http://dx.doi.org/10.1371/journal.pgen.1002937 |
_version_ | 1782242067738525696 |
---|---|
author | Szabo, Roman Uzzun Sales, Katiuchia Kosa, Peter Shylo, Natalia A. Godiksen, Sine Hansen, Karina K. Friis, Stine Gutkind, J. Silvio Vogel, Lotte K. Hummler, Edith Camerer, Eric Bugge, Thomas H. |
author_facet | Szabo, Roman Uzzun Sales, Katiuchia Kosa, Peter Shylo, Natalia A. Godiksen, Sine Hansen, Karina K. Friis, Stine Gutkind, J. Silvio Vogel, Lotte K. Hummler, Edith Camerer, Eric Bugge, Thomas H. |
author_sort | Szabo, Roman |
collection | PubMed |
description | Loss of either hepatocyte growth factor activator inhibitor (HAI)-1 or -2 is associated with embryonic lethality in mice, which can be rescued by the simultaneous inactivation of the membrane-anchored serine protease, matriptase, thereby demonstrating that a matriptase-dependent proteolytic pathway is a critical developmental target for both protease inhibitors. Here, we performed a genetic epistasis analysis to identify additional components of this pathway by generating mice with combined deficiency in either HAI-1 or HAI-2, along with genes encoding developmentally co-expressed candidate matriptase targets, and screening for the rescue of embryonic development. Hypomorphic mutations in Prss8, encoding the GPI-anchored serine protease, prostasin (CAP1, PRSS8), restored placentation and normal development of HAI-1–deficient embryos and prevented early embryonic lethality, mid-gestation lethality due to placental labyrinth failure, and neural tube defects in HAI-2–deficient embryos. Inactivation of genes encoding c-Met, protease-activated receptor-2 (PAR-2), or the epithelial sodium channel (ENaC) alpha subunit all failed to rescue embryonic lethality, suggesting that deregulated matriptase-prostasin activity causes developmental failure independent of aberrant c-Met and PAR-2 signaling or impaired epithelial sodium transport. Furthermore, phenotypic analysis of PAR-1 and matriptase double-deficient embryos suggests that the protease may not be critical for focal proteolytic activation of PAR-2 during neural tube closure. Paradoxically, although matriptase auto-activates and is a well-established upstream epidermal activator of prostasin, biochemical analysis of matriptase- and prostasin-deficient placental tissues revealed a requirement of prostasin for conversion of the matriptase zymogen to active matriptase, whereas prostasin zymogen activation was matriptase-independent. |
format | Online Article Text |
id | pubmed-3431340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34313402012-09-05 Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation Szabo, Roman Uzzun Sales, Katiuchia Kosa, Peter Shylo, Natalia A. Godiksen, Sine Hansen, Karina K. Friis, Stine Gutkind, J. Silvio Vogel, Lotte K. Hummler, Edith Camerer, Eric Bugge, Thomas H. PLoS Genet Research Article Loss of either hepatocyte growth factor activator inhibitor (HAI)-1 or -2 is associated with embryonic lethality in mice, which can be rescued by the simultaneous inactivation of the membrane-anchored serine protease, matriptase, thereby demonstrating that a matriptase-dependent proteolytic pathway is a critical developmental target for both protease inhibitors. Here, we performed a genetic epistasis analysis to identify additional components of this pathway by generating mice with combined deficiency in either HAI-1 or HAI-2, along with genes encoding developmentally co-expressed candidate matriptase targets, and screening for the rescue of embryonic development. Hypomorphic mutations in Prss8, encoding the GPI-anchored serine protease, prostasin (CAP1, PRSS8), restored placentation and normal development of HAI-1–deficient embryos and prevented early embryonic lethality, mid-gestation lethality due to placental labyrinth failure, and neural tube defects in HAI-2–deficient embryos. Inactivation of genes encoding c-Met, protease-activated receptor-2 (PAR-2), or the epithelial sodium channel (ENaC) alpha subunit all failed to rescue embryonic lethality, suggesting that deregulated matriptase-prostasin activity causes developmental failure independent of aberrant c-Met and PAR-2 signaling or impaired epithelial sodium transport. Furthermore, phenotypic analysis of PAR-1 and matriptase double-deficient embryos suggests that the protease may not be critical for focal proteolytic activation of PAR-2 during neural tube closure. Paradoxically, although matriptase auto-activates and is a well-established upstream epidermal activator of prostasin, biochemical analysis of matriptase- and prostasin-deficient placental tissues revealed a requirement of prostasin for conversion of the matriptase zymogen to active matriptase, whereas prostasin zymogen activation was matriptase-independent. Public Library of Science 2012-08-30 /pmc/articles/PMC3431340/ /pubmed/22952456 http://dx.doi.org/10.1371/journal.pgen.1002937 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Szabo, Roman Uzzun Sales, Katiuchia Kosa, Peter Shylo, Natalia A. Godiksen, Sine Hansen, Karina K. Friis, Stine Gutkind, J. Silvio Vogel, Lotte K. Hummler, Edith Camerer, Eric Bugge, Thomas H. Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation |
title | Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation |
title_full | Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation |
title_fullStr | Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation |
title_full_unstemmed | Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation |
title_short | Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation |
title_sort | reduced prostasin (cap1/prss8) activity eliminates hai-1 and hai-2 deficiency–associated developmental defects by preventing matriptase activation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431340/ https://www.ncbi.nlm.nih.gov/pubmed/22952456 http://dx.doi.org/10.1371/journal.pgen.1002937 |
work_keys_str_mv | AT szaboroman reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT uzzunsaleskatiuchia reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT kosapeter reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT shylonataliaa reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT godiksensine reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT hansenkarinak reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT friisstine reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT gutkindjsilvio reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT vogellottek reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT hummleredith reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT camerereric reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation AT buggethomash reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation |